Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7617248 | 0.98 | PDPK1 (0.48) | PDPK1LTA4HSLC6A3ALDH1A1CALM1 | |
| Hydrochloric Acid SCHEMBL3930720 | 0.98 | PDPK1 (0.48) | PDPK1LTA4HSLC6A3ALDH1A1CALM1 | |
| SCHEMBL27529418 | 0.84 | LTA4H (0.39) | PDPK1LTA4HSLC6A3ALDH1A1KDM1A | |
| SCHEMBL6163997 | 0.83 | CYP17A1 (0.50) | PDPK1LTA4HSLC6A3ALDH1A1NR1H3 | |
| SCHEMBL6657646 | 0.82 | PDPK1 (0.48) | PDPK1SLC6A3KDM1AMAOBPLA2G4A | |
| SCHEMBL6167806 | 0.81 | NR1H3 (0.56) | NR1H3SMN1; SMN2 | |
| SCHEMBL27409873 | 0.81 | PDPK1 (0.41) | PDPK1LTA4HSLC6A3ALDH1A1KDM1A | |
| SCHEMBL6821892 | 0.80 | LTA4H (0.49) | LTA4HNR1H3 | |
| SCHEMBL2973461 | 0.80 | LTA4H (0.49) | LTA4HALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL27855068 | 0.80 | CYP2C19 (0.50) | LTA4HALDH1A1KDM4ESMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 659 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12331239-B2 | Composition and process for selectively etching a layer comprising an aluminium compound in the presence of layers of low-k materials, copper and/or cobalt | BASF SE (DE) | 2025-06-17 | — | — | US | claimed |
| US-20240093089-A1 | COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT | BASF SE (DE) | 2024-03-21 | — | — | US | claimed |
| US-20230390259-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2023-12-07 | — | — | US | claimed |
| WO-2021191541-A1 | UNIVERSAL TANNIN AND FLAVOURING-BASED COMPOSITION AND USE THEREOF FOR IMPROVING THE ORGANOLEPTIC QUALITY OF A BEVERAGE | ADDEVISTA (FR) | 2021-09-30 | — | — | WO | claimed |
| US-20210085658-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING PYRIDONE DERIVATIVES | SK BIOPHARMACEUTICALS CO., LTD. | 2021-03-25 | — | — | US | claimed |
| US-20200339523-A1 | COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT | BASF SE (DE) | 2020-10-29 | — | — | US | claimed |
| US-10456385-B2 | Pharmaceutical composition comprising pyridone derivatives | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2019-10-29 | — | — | US | claimed |
| CN-109627088-A | A kind of Intelligent controlled release medicine fat particles agent of nitrile compounds containing aryl-pyrrolidine and pyridine insecticides | 河南好年景生物发展有限公司 | 2019-04-16 | — | — | CN | claimed |
| US-20180263965-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES | SK BIOPHARMACEUTICALS CO LTD (KR) | 2018-09-20 | — | — | US | claimed |
| US-9987259-B2 | Pharmaceutical composition comprising pyridone derivatives | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2018-06-05 | — | — | US | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
| EP-0346522-A2 | Printed wiring board | Nippon CMK Corp. (JP) | 1989-12-20 | — | — | EP | claimed |
| US-4826972-A | Method for preparing crystalline cephalosporin derivative | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 1989-05-02 | — | — | US | claimed |
| EP-0272692-A2 | Condensation copolymers containing bis-methine moieties and products therefrom | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-06-29 | — | — | EP | claimed |
| US-4741990-A | AROMATIC FLUORINE COMPOUND AS ANTIFOGGING AGENT | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1988-05-03 | — | — | US | claimed |
| EP-0237256-A2 | Method for processing silver halide photographic light-sensitive materials | KONICA CORPORATION (JP) | 1987-09-16 | — | — | EP | claimed |
| US-4692449-A | ANTIASTHMATIC AND ANTIALLERGIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1987-09-08 | — | — | US | claimed |
| EP-0099770-B1 | OXAZINOBENZOTHIAZINE-6,6-DIOXIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENT | PROVESAN S.A. (CH) | 1986-08-27 | — | — | EP | claimed |
| EP-0063109-B1 | THERAPEUTICALLY ACTIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PHARMACIA AB (SE) | 1986-07-16 | — | — | EP | claimed |
| US-4259336-A | ANALGESIC, ANTIPYRETIC, ANTITHROMBOTIC, ANTIPHLOGISTIC | BOEHRINGER INGELHEIM GMBH (DE) | 1981-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240093089-A1 | COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT | STK11, CRKL, STK10 | PDPK1 168/4885LTA4H 1857/4885SLC6A3 3275/4885 |
| US-20200339523-A1 | COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT | STK11, ASH2L, CRKL | PDPK1 281/4885LTA4H 2471/4885SLC6A3 3610/4885 |
| US-20180263965-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES | PLPBP, PDXK, PIR | PDPK1 426/4885LTA4H 2002/4885SLC6A3 209/4885 |
| US-20230390259-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES | PLPBP, PDXK, PIR | PDPK1 426/4885LTA4H 2002/4885SLC6A3 209/4885 |
| US-12331239-B2 | Composition and process for selectively etching a layer comprising an aluminium compound in the presence of layers of low-k materials, copper and/or cobalt | STK11, CRKL, STK10 | PDPK1 168/4885LTA4H 1857/4885SLC6A3 3275/4885 |
| US-10456385-B2 | Pharmaceutical composition comprising pyridone derivatives | PLPBP, PDXK, PIR | PDPK1 426/4885LTA4H 2002/4885SLC6A3 209/4885 |
| US-20210085658-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING PYRIDONE DERIVATIVES | PLPBP, PDXK, PNPO | PDPK1 426/4885LTA4H 2074/4885SLC6A3 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.